Abstract:Down‐regulation of p57 (KIP2) cyclin‐dependent kinase inhibitors accelerates the growth and invasion of hepatocellular carcinoma (HCC), suggesting that p57 may play an important role in liver carcinogenesis. However, the mechanism or oncogenic signal leading to p57 down‐regulation in HCC remains to be determined. Herein, we demonstrated that Jab1/Csn5 expression is negatively correlated with p57 levels in HCC tissues. Kaplan‐Meier analysis of tumor samples revealed that high Jab1/Csn5 expression with concurrent low p57 expression is associated with poor overall survival. The inverse pattern of Jab1 and p57 expression was also observed during carcinogenesis in a chemically induced rat HCC model. We also found that mechanistically, Jab1‐mediated p57 proteolysis in HCC cells is dependent on 26S‐proteasome inhibitors. We further demonstrated that direct physical interaction between Jab1 and p57 triggers p57 down‐regulation, independently of Skp2 and Akt pathways, in HCC cells. These data suggest that Jab1 is an important upstream negative regulator of p57 and that aberrant expression of Jab1 in HCC could lead to a significant decrease in p57 levels and contribute to tumor cell growth. Furthermore, restoration of p57 levels induced by loss of Jab1 inhibited tumor cell growth and further increased cell apoptosis in HCC cells. Moreover, silencing Jab1 expression further enhanced the antitumor effects of cisplatin‐induced apoptosis in HCC cells. Conclusion: Jab1‐p57 pathway confers resistance to chemotherapy and may represent a potential target for investigational therapy in HCC. (Hepatology 2016;63:898–913)

Jab1 promotes gastric cancer tumorigenesis via non-ubiquitin proteasomal degradation of p14ARF

The E3 Ligase Ring1 Targets P53 For Degradation And Promotes Cancer Cell Proliferation And Survival

Role of REG Iα in Gastric Carcinogenesis: Gastrin-associated Proliferative and Anti-Apoptotic Activities.

LARP7 is a BRCA1 Ubiquitinase Substrate and Regulates Genome Stability and Tumorigenesis

Jab1 interacts with brain-specific kinase 2 (BRSK2) and promotes its degradation in the ubiquitin-proteasome pathway.

Downregulation of AZGP1 by Ikaros and Histone Deacetylase Promotes Tumor Progression Through the PTEN/Akt and CD44s Pathways in Hepatocellular Carcinoma.

Down-Regulation of the Cyclin-Dependent Kinase Inhibitor P57 is Mediated by Jab1/Csn5 in Hepatocarcinogenesis

USP29 activation mediated by FUBP1 promotes AURKB stability and oncogenic functions in gastric cancer

Suppression of PTP1B in Gastric Cancer Cells in Vitro Induces a Change in the Genome-Wide Expression Profile and Inhibits Gastric Cancer Cell Growth.

RNF185 Modulates JWA Ubiquitination and Promotes Gastric Cancer Metastasis.

Effect of Jab1 Gene RNAi on Proliferation and Migration of Breast Cancer MCF-7 Cells

Frequent Amplification of AIB1, a Critical Oncogene Modulating Major Signaling Pathways, is Associated with Poor Survival in Gastric Cancer

Synergistic Role Between P53 and JWA: Prognostic and Predictive Biomarkers in Gastric Cancer.

Rab14 Act As Oncogene And Induce Proliferation Of Gastric Cancer Cells Via Akt Signaling Pathway

The UbL-UBA Ubiquilin4 Protein Functions As a Tumor Suppressor in Gastric Cancer by P53-Dependent and P53-Independent Regulation of P21

Small GTPase RBJ Mediates Nuclear Entrapment of MEK1/MEK2 in Tumor Progression

PTP1B Expression Contributes to Gastric Cancer Progression.

YTHDF1 Promotes Gastric Carcinogenesis by Controlling Translation of FZD7

WWP1 As a Potential Tumor Oncogene Regulates PTEN-Akt Signaling Pathway in Human Gastric Carcinoma.

PIN1P1 is activated by CREB1 and promotes gastric cancer progression via interacting with YBX1 and upregulating PIN1

DUB1 Suppresses Hippo Signaling Via Modulating TAZ Protein in Gastric Cancer